CY1308A
(en)
|
1979-12-06 |
1985-12-06 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
US4353656A
(en)
|
1980-10-14 |
1982-10-12 |
Xerox Corporation |
Moving coil, multiple energy print hammer system including a closed loop servo
|
DE3274065D1
(de)
|
1981-07-08 |
1986-12-11 |
Draco Ab |
Powder inhalator
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
CA1224992A
(en)
|
1982-10-08 |
1987-08-04 |
Robert E. Newell |
Device for administering medicament to patients
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
US4775761A
(en)
|
1983-08-22 |
1988-10-04 |
Hoechst-Roussel Pharmaceuticals, Inc. |
3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
|
DE3342632A1
(de)
|
1983-11-25 |
1985-06-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Indolderivate
|
US5256673A
(en)
|
1983-11-25 |
1993-10-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
|
FR2585563B1
(fr)
|
1985-07-30 |
1993-11-12 |
Glaxo Group Ltd |
Dispositif pour administrer des medicaments a des patients
|
EP0279263B1
(en)
|
1987-02-10 |
1993-08-04 |
Abbott Laboratories |
Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds
|
JPH0262875A
(ja)
|
1988-05-23 |
1990-03-02 |
Wakunaga Pharmaceut Co Ltd |
新規イソインドリン誘導体
|
IL95584A
(en)
|
1989-09-07 |
1995-03-15 |
Abbott Lab |
Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
US5254473A
(en)
|
1990-03-16 |
1993-10-19 |
Jp Laboratories |
Solid state device for monitoring integral values of time and temperature of storage of perishables
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
JP2963288B2
(ja)
|
1992-01-14 |
1999-10-18 |
株式会社海洋バイオテクノロジー研究所 |
水中有害付着生物防除剤
|
CZ283425B6
(cs)
|
1992-04-02 |
1998-04-15 |
Smithkline Beecham Corporation |
Fenylové deriváty a farmaceutické prostředky s jejich obsahem
|
US5256873A
(en)
*
|
1992-09-03 |
1993-10-26 |
Eaton Corporation |
Multiple station through beam photoelectric sensor
|
US5330986A
(en)
|
1992-11-24 |
1994-07-19 |
Hoechst-Roussel Pharmaceuticals Inc. |
Indole-7-carboxamide derivatives
|
FR2701026B1
(fr)
|
1993-02-02 |
1995-03-31 |
Adir |
Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
|
GB9305623D0
(en)
|
1993-03-18 |
1993-05-05 |
Merck Sharp & Dohme |
Therapeutic agents
|
US5576336A
(en)
|
1993-03-18 |
1996-11-19 |
Merck Sharp & Dohme Limited |
Indole derivatives as dopamine D4 antagonists
|
BR9406946A
(pt)
*
|
1993-07-06 |
1996-08-06 |
Pfizer |
Tetra-hidro-pirazolpiridinas bicíclicas
|
ATE191470T1
(de)
|
1994-06-15 |
2000-04-15 |
Wellcome Found |
Enzymhemmer
|
ZA951822B
(en)
|
1994-12-23 |
1996-09-26 |
Glaxo Group Ltd |
Chemical compounds
|
DE19500689A1
(de)
|
1995-01-12 |
1996-07-18 |
Merck Patent Gmbh |
Indolpiperidin-Derivate
|
WO1996028367A2
(en)
|
1995-03-10 |
1996-09-19 |
Minnesota Mining And Manufacturing Company |
Aerosol valves
|
MX9709442A
(es)
|
1995-06-07 |
1998-02-28 |
Sugen Inc |
Metodo y composiciones para la inhibicion de interacciones entre proteina adaptadora y tirosinquinasa.
|
GB9610811D0
(en)
|
1996-05-23 |
1996-07-31 |
Pharmacia Spa |
Combinatorial solid phase synthesis of a library of indole derivatives
|
US5846982A
(en)
|
1996-06-14 |
1998-12-08 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
EP1077213A3
(en)
|
1996-06-14 |
2001-06-13 |
Eli Lilly And Company |
Inhibition of serotonin reuptake
|
JP2001506230A
(ja)
|
1996-08-09 |
2001-05-15 |
スミスクライン・ビーチャム・コーポレイション |
新規ピペラジン含有化合物
|
WO1998028292A1
(en)
|
1996-12-23 |
1998-07-02 |
Smithkline Beecham Corporation |
Novel piperidine containing compounds
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
BR9811821A
(pt)
|
1997-08-06 |
2000-08-15 |
Lilly Co Eli |
2-acilaminopropanaminas como antagonistas de receptores de taquicinina
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
AR013669A1
(es)
|
1997-10-07 |
2001-01-10 |
Smithkline Beecham Corp |
Compuestos y metodos
|
DE19756036A1
(de)
|
1997-12-17 |
1999-06-24 |
Merck Patent Gmbh |
Amid- und Harnstoffderivate
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
DE19807993A1
(de)
|
1998-02-26 |
1999-09-02 |
Bayer Ag |
Verwendung von ß-Carbolinderivaten zur Bekämpfung von TNF-alpha-abhängigen Krankheiten
|
ES2220043T3
(es)
|
1998-02-27 |
2004-12-01 |
Kissei Pharmaceutical Co., Ltd. |
Derivados del indol y composiciones medicinales que los contienen.
|
EP1070056B1
(en)
|
1998-03-14 |
2004-06-30 |
ALTANA Pharma AG |
Phthalazinone pde iii/iv inhibitors
|
US6589954B1
(en)
|
1998-05-22 |
2003-07-08 |
Scios, Inc. |
Compounds and methods to treat cardiac failure and other disorders
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
CA2336254A1
(en)
|
1998-06-30 |
2000-01-06 |
Daniel James Koch |
5-ht1f agonists
|
DE19928424A1
(de)
|
1999-06-23 |
2000-12-28 |
Aventis Pharma Gmbh |
Substituierte Benzimidazole
|
RU2261248C2
(ru)
|
1999-06-23 |
2005-09-27 |
Авентис Фарма Дойчланд Гмбх |
Замещенные бензимидазолы и лекарственное средство на их основе
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
AR025111A1
(es)
|
1999-08-13 |
2002-11-06 |
Janus Pharmaceuticals Inc |
Metodos y composiciones para tratar trastornos de ansiedad generalizada
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
US6245799B1
(en)
|
1999-11-08 |
2001-06-12 |
American Home Products Corp |
[(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders
|
CN1414962A
(zh)
|
1999-11-08 |
2003-04-30 |
惠氏公司 |
用于治疗中枢神经系统疾病的[(吲哚-3-基)-环烷基]-3-取代的氮杂环丁烷
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
US6632666B2
(en)
|
2000-01-14 |
2003-10-14 |
Biolife Solutions, Inc. |
Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
|
GB0003154D0
(en)
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
EP1134221A1
(en)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines as lkB kinase inhibitors
|
EP1268477B1
(en)
|
2000-03-15 |
2010-04-21 |
Sanofi-Aventis Deutschland GmbH |
Substituted beta-carbolines with ikb-kinase inhibiting activity
|
EP1209158A1
(en)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Substituted beta-carbolines
|
JP2003531205A
(ja)
|
2000-04-24 |
2003-10-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
Impdh酵素の阻害剤である複素環化合物
|
BR0110420A
(pt)
|
2000-04-28 |
2003-07-01 |
Acadia Pharm Inc |
Agonistas muscarìnicos
|
AU2001256714A1
(en)
|
2000-05-15 |
2001-11-26 |
Kissei Pharmaceutical Co. Ltd. |
Water-based liquid preparation
|
US6414013B1
(en)
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
AU2001275760B2
(en)
|
2000-08-05 |
2005-03-17 |
Glaxo Group Limited |
6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid S-fluoromethyl ester as an anti-inflammatory agent
|
MXPA03001420A
(es)
|
2000-08-14 |
2004-01-26 |
Johnson & Johnson |
Pirazoles sustituidos.
|
AU2001279958A1
(en)
|
2000-08-17 |
2002-03-04 |
Celltech R And D Limited |
Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders
|
US6868504B1
(en)
*
|
2000-08-31 |
2005-03-15 |
Micron Technology, Inc. |
Interleaved delay line for phase locked and delay locked loops
|
US6579896B2
(en)
|
2000-09-06 |
2003-06-17 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for treating allergies using substituted pyrazoles
|
JP4272338B2
(ja)
|
2000-09-22 |
2009-06-03 |
バイエル アクチェンゲゼルシャフト |
ピリジン誘導体
|
US7101882B2
(en)
|
2000-09-29 |
2006-09-05 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
AU1182702A
(en)
|
2000-10-03 |
2002-04-15 |
Bristol Myers Squibb Co |
Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
|
US6869956B2
(en)
|
2000-10-03 |
2005-03-22 |
Bristol-Myers Squibb Company |
Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
|
WO2002030423A1
(en)
|
2000-10-12 |
2002-04-18 |
Smithkline Beecham Corporation |
NF-λB INHIBITORS
|
AU2002211663A1
(en)
|
2000-10-12 |
2002-04-22 |
Smith Kline Beecham Corporation |
Nf-$g(k)b inhibitors
|
ATE392898T1
(de)
|
2000-10-26 |
2008-05-15 |
Amgen Inc |
Antiphlogistische mittel
|
JP2002193938A
(ja)
|
2000-12-01 |
2002-07-10 |
Bayer Ag |
4−アリールピリジン誘導体
|
US7122544B2
(en)
|
2000-12-06 |
2006-10-17 |
Signal Pharmaceuticals, Llc |
Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
EA200300717A1
(ru)
|
2000-12-22 |
2003-12-25 |
Уайт |
Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
EP1363993A4
(en)
|
2001-02-01 |
2008-11-12 |
Bristol Myers Squibb Co |
METHOD FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISEASES USING I KAPPA B KINASE (IKK)
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
EP1366025B1
(en)
|
2001-03-08 |
2007-06-27 |
Glaxo Group Limited |
Agonists of beta-adrenoreceptors
|
DE10112151A1
(de)
|
2001-03-14 |
2002-09-19 |
Merck Patent Gmbh |
Substituierte Benzofuran-2-carbonsäureamide
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
HUP0400070A2
(hu)
|
2001-04-30 |
2004-04-28 |
Glaxo Group Limited |
17alfa-helyzetben ciklusos észtercsoportot tartalmazó androsztán-17béta-karbotiosav-észter-származékok mint gyulladásgátló szerek, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények
|
DE60233656D1
(de)
|
2001-05-24 |
2009-10-22 |
Leo Pharma As |
Pyridylcyanoguanidin verbindungen
|
WO2002094265A1
(en)
|
2001-05-24 |
2002-11-28 |
Leo Pharma A/S |
A method of modulating nf-$g(k)b activity
|
US20030045515A1
(en)
|
2001-05-24 |
2003-03-06 |
Lise Binderup |
Combination medicament for treatment of neoplastic diseases
|
KR100600240B1
(ko)
|
2001-06-07 |
2006-07-13 |
에프. 호프만-라 로슈 아게 |
5-ht6 수용체 친화도를 갖는 신규한 인돌 유도체
|
JP2005500290A
(ja)
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、17β−カルボチオアートアンドロスタン誘導体である17α複素環エステル
|
US6638679B2
(en)
|
2001-07-12 |
2003-10-28 |
Kodak Polychrome Graphics, Llc |
Photosensitive compositions having mixtures of alkoxy and non-alkoxy diazonium salt containing compounds
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
SE0102617D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
US20030127204A1
(en)
|
2001-09-06 |
2003-07-10 |
Varnell Daniel F. |
Amphoteric polymer resins that increase the rate of sizing development
|
ATE417606T1
(de)
|
2001-09-14 |
2009-01-15 |
Glaxo Group Ltd |
Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
|
JP2005506983A
(ja)
|
2001-09-19 |
2005-03-10 |
ファルマシア・コーポレーション |
炎症の治療のための置換ピラゾリル化合物
|
CA2460939C
(en)
|
2001-09-19 |
2008-07-29 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
JP2005507922A
(ja)
|
2001-09-19 |
2005-03-24 |
ファルマシア・コーポレイション |
炎症の治療のための置換されたインダゾール化合物
|
JP2005507892A
(ja)
|
2001-09-19 |
2005-03-24 |
ファルマシア・コーポレーション |
炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物
|
CA2464924A1
(en)
|
2001-10-30 |
2003-05-08 |
Pharmacia Corporation |
Heteroaromatic carboxamide derivatives for the treatment of inflammation
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
ATE346058T1
(de)
|
2002-01-14 |
2006-12-15 |
Boehringer Ingelheim Pharma |
Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
|
JP4745609B2
(ja)
|
2002-01-22 |
2011-08-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
グルココルチコイドレセプターのための非ステロイド性リガンド、その組成物および使用
|
US6646785B2
(en)
|
2002-01-31 |
2003-11-11 |
Corning Incorporated |
Fiber ring amplifiers and lasers
|
CA2475659A1
(en)
|
2002-02-14 |
2003-08-21 |
Glaxo Group Limited |
Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
EA008830B1
(ru)
|
2002-03-26 |
2007-08-31 |
Бёрингер Ингельхайм Фармасьютиклз, Инк. |
Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
WO2003084959A1
(en)
|
2002-04-03 |
2003-10-16 |
Bristol-Myers Squibb Company |
Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same
|
AU2003224257A1
(en)
|
2002-04-09 |
2003-10-27 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
AR039280A1
(es)
|
2002-04-11 |
2005-02-16 |
Smithkline Beecham Corp |
Compuesto de aminotiofeno y su uso para preparar una composicion farmaceutica
|
US7282591B2
(en)
|
2002-04-11 |
2007-10-16 |
Merck & Co., Inc. |
1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
JP2005523920A
(ja)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
フェネタノールアミン誘導体
|
MXPA04010952A
(es)
|
2002-05-09 |
2005-01-25 |
Pharmacia Corp |
Compuestos de pirazolilo sustituidos para el tratamiento de la inflamacion.
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
WO2003101987A1
(en)
|
2002-05-30 |
2003-12-11 |
Neurosearch A/S |
3-substituted quinuclidines and their use
|
CN100386329C
(zh)
|
2002-06-06 |
2008-05-07 |
贝林格尔.英格海姆药物公司 |
取代的3-氨基-噻吩并[2,3-b]吡啶-2-羧酸酰胺化合物及其制备方法和用途
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
AU2003249683A1
(en)
|
2002-06-06 |
2003-12-22 |
Smithkline Beecham Corporation |
Nf-:b inhibitors
|
ES2518940T3
(es)
|
2002-07-08 |
2014-11-06 |
Pfizer Products Inc. |
Moduladores del receptor de glucocorticoides
|
US6995181B2
(en)
|
2002-07-18 |
2006-02-07 |
Bristol-Myers Squibb Co. |
Modulators of the glucocorticoid receptor and method
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
DE60333371D1
(de)
|
2002-08-29 |
2010-08-26 |
Boehringer Ingelheim Pharma |
3-(sulfonamidoethyl)-indol-derivate zur verwendung als glucocorticoid-mimetika bei der behandlung von entzündlichen, allergischen und proliferativen erkrankungen
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
US6919334B2
(en)
|
2002-09-12 |
2005-07-19 |
Wyeth |
Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
|
US6911445B2
(en)
|
2002-09-12 |
2005-06-28 |
Wyeth |
Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
|
US7135479B2
(en)
|
2002-09-12 |
2006-11-14 |
Wyeth |
Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
|
CN100387598C
(zh)
|
2002-09-16 |
2008-05-14 |
葛兰素集团有限公司 |
吡唑并[3,4-b]吡啶化合物及其作为磷酸二酯酶抑制剂的用途
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
JP4520309B2
(ja)
|
2002-09-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的糖質コルチコイド受容体調節剤としてのオクタヒドロ−2−H−ナフト[1,2−f]インドール−4−カルボキサミド誘導体
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
AU2003298094A1
(en)
|
2002-10-22 |
2004-05-13 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR041724A1
(es)
|
2002-10-28 |
2005-05-26 |
Glaxo Group Ltd |
Compuestos derivados de fenetanolamina y su utilizacion en composiciones farmaceuticas
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
ES2309368T3
(es)
|
2002-12-02 |
2008-12-16 |
F. Hoffmann-La Roche Ag |
Derivados de indazol como antagonista del crf.
|
US20060116419A1
(en)
|
2002-12-06 |
2006-06-01 |
Callahan James F |
Nf-kb inhibitors
|
DE10259244A1
(de)
|
2002-12-17 |
2004-07-01 |
Merck Patent Gmbh |
N-(Indolethyl-)cycloamin-Verbindungen
|
US7329668B2
(en)
|
2003-02-25 |
2008-02-12 |
Bristol-Myers Squibb Company |
Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
|
GB0308466D0
(en)
|
2003-04-11 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
US7176214B2
(en)
|
2003-05-21 |
2007-02-13 |
Bristol-Myers Squibb Company |
Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
WO2005012283A1
(en)
|
2003-07-31 |
2005-02-10 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted benzothiophene compounds and uses thereof
|
US7291733B2
(en)
|
2003-10-10 |
2007-11-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted tricyclic heterocycles and their uses
|
BRPI0415390A
(pt)
|
2003-10-14 |
2006-12-12 |
Pharmacia Corp |
compostos de pirazinona substituìda para o tratamento da inflamação
|
EP1677795B1
(en)
|
2003-10-14 |
2011-01-05 |
Glaxo Group Limited |
Muscarinic acetycholine receptor antagonists
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
WO2005051942A1
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
AU2004299277A1
(en)
|
2003-12-19 |
2005-06-30 |
Glaxo Group Limited |
Pyrazolo (3,4-b) pyridine compounds, and their use as phosphodiesterase inhibitors
|
EP1694686A1
(en)
|
2003-12-19 |
2006-08-30 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
GB0400895D0
(en)
*
|
2004-01-15 |
2004-02-18 |
Smithkline Beecham Corp |
Chemical compounds
|
DE102004012069A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue aryl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US20080275078A1
(en)
|
2004-03-16 |
2008-11-06 |
Glaxo Group Limited |
Pyrazolo[3,4-B] Pyridine Compounds and Their Use as Pde4 Inhibitors
|
GB0405937D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
AR050902A1
(es)
|
2004-04-27 |
2006-12-06 |
Glaxo Group Ltd |
Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
|
TW200616967A
(en)
|
2004-06-24 |
2006-06-01 |
Smithkline Beecham Corp |
Novel indazole carboxamides and their use
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
PE20060748A1
(es)
|
2004-09-21 |
2006-10-01 |
Smithkline Beecham Corp |
Derivados de indolcarboxamida como inhibidores de quinasa ikk2
|
BRPI0518222A
(pt)
|
2004-10-19 |
2008-11-04 |
Hoffmann La Roche |
composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos
|
EP1841780B1
(en)
|
2005-01-10 |
2011-07-27 |
Glaxo Group Limited |
Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
AU2006232620A1
(en)
|
2005-04-06 |
2006-10-12 |
Astrazeneca Ab |
Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors
|
EA013123B1
(ru)
|
2005-04-13 |
2010-02-26 |
Ньюрэксон, Инк. |
Замещенные индолы, обладающие активностью ингибирования nos
|
JP2009507746A
(ja)
|
2005-06-14 |
2009-02-26 |
コンストラクション リサーチ アンド テクノロジー ゲーエムベーハー |
セメント状組成物に耐凍性および融解抵抗性を付与する方法
|
BRPI0611674A2
(pt)
*
|
2005-06-30 |
2009-04-28 |
Smithkline Beecham Corp |
compostos quÍmicos
|
US8063071B2
(en)
|
2007-10-31 |
2011-11-22 |
GlaxoSmithKline, LLC |
Chemical compounds
|
US7956082B2
(en)
|
2005-07-22 |
2011-06-07 |
Shionogi & Co., Ltd |
Indole derivative having PGD2 receptor antagonist activity
|
US20080242685A1
(en)
|
2005-10-25 |
2008-10-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
US20080262040A1
(en)
|
2005-10-25 |
2008-10-23 |
Smithkline Beecham Corporation |
Chemical Compounds
|
JP2009516702A
(ja)
|
2005-11-18 |
2009-04-23 |
スミスクライン・ビーチャム・コーポレイション |
化合物
|
US20080293802A1
(en)
|
2005-12-16 |
2008-11-27 |
Smithline Beecham Corporation |
Chemical Compounds
|
US8008481B2
(en)
|
2006-03-31 |
2011-08-30 |
Ericsson Anna M |
Indazole compounds
|
DE602007011645D1
(de)
|
2006-09-22 |
2011-02-10 |
Glaxo Group Ltd |
Pyrroloä2, 3-büpyridin-4-yl-benzolsulfonamidverbindungen als ikk2-hemmer
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
GB0710528D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0804592D0
(en)
|
2008-03-12 |
2008-04-16 |
Glaxo Group Ltd |
Novel compounds
|
EP2406249A1
(en)
|
2009-03-10 |
2012-01-18 |
Glaxo Group Limited |
Indole derivatives as ikk2 inhibitors
|
WO2010106016A1
(en)
|
2009-03-17 |
2010-09-23 |
Glaxo Group Limited |
Pyrimidine derivatives used as itk inhibitors
|